Omega-3 Hydrogel and Prevention of Oral Mucositis

  • STATUS
    Recruiting
  • days left to enroll
    14
  • participants needed
    36
  • sponsor
    Basma Morsy
Updated on 20 July 2022

Summary

Oral mucositis (OM) is recognized as one of the most frequent debilitating sequela encountered by head and neck cancer (HNC) patients treated by radiotherapy. The objective of the study is to assess primarily the effect of topical oral Omega-3 hydrogel in prevention of radiation-induced oral mucositis and secondarily, to test the effect of topical oral Omega-3 hydrogel on oral microbiome.

Details
Condition Mucositis Oral
Treatment topical oral Omega-3 hydrogel, conventional preventive treatment
Clinical Study IdentifierNCT05214495
SponsorBasma Morsy
Last Modified on20 July 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients who are going to receive radiotherapy as a treatment of head and neck cancer either as postoperative (adjuvant) therapy or definitive therapy
Patients whose radiotherapy treatment planned dose is 50 Gy or above
Males and females with an age not less than 18 years
Patients receiving radiotherapy alone or receiving concomitant cisplatin (or carboplatin) with radiotherapy

Exclusion Criteria

Patients under Anticoagulants such as warfarin, heparin, or aspirin
Patients suffering from any uncontrolled systemic diseases (such as diabetes, cardiovascular, liver disorder, renal dysfunction)
Patients with findings of any physical or mental abnormality which would interfere with or be affected by the study procedure
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note